5 Key Takeaways

• 1

  Pharmaceutical supply chain carbon reduction relies on network position rather than just emission levels.

• 2

  Central players like logistics hubs can significantly influence a product's carbon footprint despite low direct emissions.

• 3

  The study utilized life cycle assessment and social network analysis to evaluate emissions for three drugs.

• 4

  The responsibility contribution index ranks supply chain nodes by emission intensity and structural influence.

• 5

  Targeting nodes with high emissions and strong network control can enhance decarbonization strategies in pharma.